Publications
Driving Precision Oncology Research
Every day, new discoveries confirm the increasing and important role biomarker analysis and tumor profiling have in personalized cancer care. We contribute to the body of research in oncology to advance the understanding of molecular science and further enable the delivery of precision medicine.
FEATURED
-
AI-enabled whole exome & transcriptome liquid biopsy addressing MCED, MRD, and therapy selection on a single platform
– Caris Life Sciences
Abstract Background: Cancer diagnosis, treatment and management are possible through the usage of multidisciplinary platforms. Herein, we present a unique Artificial Intelligent (AI)-enabled liquid biopsy platform that can provide sensitive and specific signals for the purpose of multi-cancer early detection (MCED), diagnosis, and therapy selection to minimal residual disease (MRD) and monitoring. Methods: We utilized… […]
Filter By
Discover
More
Caris is actively delivering on the promise of precision medicine and our pipeline reflects our future tests and molecular science-based solutions to help patients and improve the human condition.
With one of the largest, multi-modal databases of combined molecular and clinical outcomes data in the world, Caris applies highly sophisticated AI bioinformatics and machine learning capabilities on this massive database to create novel, clinically relevant solutions to classify cancer at the molecular level and predict patient response in ways never before possible.
Have questions?
"*" indicates required fields